ZORYVE cream 0.3% is a prescription medicine used on the skin (topical), including in areas with skin folds, to treat plaque psoriasis in adults and children 6 years of age and older.

Oct 8, 2025 · Zoryve cream is used to treat plaque psoriasis and atopic dermatitis, and Zoryve foam is used for seborrheic dermatitis and plaque psoriasis. Includes Zoryve side effects, dose, directions, …

Jul 14, 2024 · Find patient medical information for Zoryve (roflumilast) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

May 7, 2025 · ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older.

Feb 1, 2026 · For topical dosage form (Zoryve® 0.15% cream): For atopic dermatitis: Adults and children 6 years of age and older—Apply to the affected area of the skin once a day. Children …

Jul 14, 2024 · Zoryve (roflumilast) is a cream and foam that's approved for treating certain skin conditions in adults and children. The 0.15% cream is used to treat eczema and the 0.3% cream is …

Jul 18, 2024 · Zoryve (Roflumilast Cream) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.

If these products are co-administered with ZORYVE cream, weigh the potential for increased adverse reactions against benefit. (7.1) Co-administration of roflumilast with oral contraceptives containing …

Medscape - Plaque psoriasis Zoryve (roflumilast topical), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.

Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor used for the treatment of COPD and plaque psoriasis. Topical roflumilast 0.3% cream (Zorvye™) was approved by the FDA in 2022 for the …